183 related articles for article (PubMed ID: 7453888)
1. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
Kaemmerer E
Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
[No Abstract] [Full Text] [Related]
2. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
Dauverchain J
Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
[TBL] [Abstract][Full Text] [Related]
3. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG
Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895
[No Abstract] [Full Text] [Related]
4. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
Bossi L
Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
Karyofilis A
Ther Ggw; 1980 Dec; 119(12):1478-85. PubMed ID: 7466692
[No Abstract] [Full Text] [Related]
6. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
Marolda M; Fragassi N; Buscaino GA
Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
[TBL] [Abstract][Full Text] [Related]
8. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
Michelangeli J; Sevilla M; Lavagna J; Darcourt G
Ann Med Psychol (Paris); 1975 Apr; 1(4):499-510. PubMed ID: 788599
[No Abstract] [Full Text] [Related]
9. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment of cerebrovascular disorder with vasoactive drugs].
Lebiediewa NW
Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
Forette F; Varin D; Henry JF; Hervy MP
Nouv Presse Med; 1980 Dec; 9(48):3685-8. PubMed ID: 7005872
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline.
Le Poncin-Lafitte M; Grosdemouge C; Duterte D; Rapin JR
Gerontology; 1984; 30(2):109-19. PubMed ID: 6706123
[TBL] [Abstract][Full Text] [Related]
13. [Use of nicergoline (IDB-1076) in the treatment of mild to moderate systemic arterial hypertension in adults and in the aged].
Rinaldi G; Nieri A; Saponati G
Minerva Cardioangiol; 1987 Oct; 35(10):573-83. PubMed ID: 3438004
[No Abstract] [Full Text] [Related]
14. [Effect of nicergoline on the intellectual performance (author's transl)].
Donoso A; Santander M; Sarce H
Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
[No Abstract] [Full Text] [Related]
15. [Effects of nicergoline on hemodynamics and metabolism of the brain in primary arterial hypertension and in arteriosclerosis].
Maiolo AT; Bianchi Porro G; Galli C; Sessa M
Clin Ter; 1972 Aug; 62(3):239-52. PubMed ID: 5081153
[No Abstract] [Full Text] [Related]
16. [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].
Lievre M; Ollagnier M; Faucon G
Arzneimittelforschung; 1979; 29(8a):1227-31. PubMed ID: 44198
[TBL] [Abstract][Full Text] [Related]
17. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
Kugler JE; Meurer-Krüll BC
Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
[TBL] [Abstract][Full Text] [Related]
18. [Effects of nicergoline on cerebral blood flow (author's transl)].
Iliff LD; Du Boulay GH; Marshall J; Ross Russell RW; Symon L
Arzneimittelforschung; 1979; 29(8a):1277-8. PubMed ID: 540071
[TBL] [Abstract][Full Text] [Related]
19. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
[TBL] [Abstract][Full Text] [Related]
20. [Rheographic study of nicergolin in the circulation of the lower limbs in healthy and arteriopathic subjects].
Boismare F; Philippe JC; Leduc X
Therapie; 1974; 29(6):925-32. PubMed ID: 4618389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
